It’s time for another #LCSM Chat! @CharuAggarwalMD will break down the most promising & important Lung Cancer research from 2 major conferences: #WCLC21 & #ESMO21. Join us this Thurs 10/7 5pm PT, 8pm ET to stay up-to-date on the “Best in Show.” Please RT to spread the word!
Genomic analysis of lung adenocarcinoma from never smokers in #JCO reveals actionable drivers in up to 92% of cases. Germline variants noted in ~7% of non-smokers and ~6% show mutational signatures of passive smoke exposure. #LCSM@ASCO_pubs@OncoAlert
https://t.co/CYVbMKu77Z
Honored to participate! The Accelerated drug approval program has been a lifeline for those of us w/rare cancers who have few tx options. THANK YOU @FDAOncology for giving us access to these breakthrough drugs & for giving patients a chance!! @RETpositive#LCSM#PrecisionMedicine
How can we best use liquid biopsy in the treatment of lung cancer? Can changes in ctDNA be used as an early pharmacodynamic marker to gauge response to immunotherapy and even trigger early changes in treatment? See report in #JCOPO@ASCO_pubs#LCSM
https://t.co/WTpveaM5z4
📆Mark your calendar for this #TumorBoardTuesday!!
🧠We’re preparing for @VivekSubbiah’s case on RET thyroid ➡️ liver!
🥇While we work BTS, you can catch up on missed conversations & collect 🆓 #CME!! https://t.co/63osUKLysL
📥Interested in leading a case? Send us a DM!
#WCLC21 The barrier to cfDNA has been cost - but we have to consider what happens next. Missing a biomarker means delivering less effective therapy, usually chemo-immunotherapy which has its own costs. This analysis shows liquid biopsy led to cost SAVINGS of $37,216 per patient.
#WCLC21 Congratulations to Dr. @DoreenEzeife and team. I do believe early integration of liquid biopsy is appropriate as it increases the odds of making the right treatment choice quickly, particularly since sequence of therapy is so critical. These data are icing on the cake.
⭐️🚨Hot off the Press 👉Molecular Cancer Therapeutics @MCT_AACR@AACR Review 👉"Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers" @OncoAlert https://t.co/tVxyPwCvQo
@PatrickCMa1 May they have a loooong and durable response!! Feel free to let them know about our support group https://t.co/H0Xtg9PT4a and our private Facebook support group if they are interested!
Engaged does not and should not mean 'Annoying' patient. It is possible to ask questions while still respecting your Onc's expertise in the subject matter. In the end our Onc's want us to be engaged, because patients who are invested in their care do better! #LCSM
@lcsmchat@RedGia This is a tough one. It can be helpful to find a support group to bounce some of your questions off of, rather than go to your onc w/everything - this can be too much for some docs. Finding trusted online resources is key. Saving only the important questions for your onc. #LCSM
T3: We become engaged when we are tired of just feeling lost and scared. When we decide to start learning about why we are being treated with this or that, or start thinking about what might come next in our treatment if the current line doesn't work. #LCSM
@jillfeldman4 Exactly this. Being engaged is being empowered! You are taking some ownership of what is going on with your health and your life. Gives you some semblance of control and assurance that you and your doc have made the best plan possible with what data is available. #LCSM
@JFreemanDaily An engaged patient is an informed patient who knows the names of the meds they are on. Who goes to their doctors with questions and sees themselves as having some power over their own care rather than seeing themselves only as a victim submitting to somebody elses plan. #LCSM
A successful marriage is all about the best match. Whether in life or in cancer therapy— targeted therapy, immunotherapy, hormonal therapy and chemotherapy.